Skip to main content
. 2022 Oct 26;611(7934):155–160. doi: 10.1038/s41586-022-05368-8

Extended Data Table 2.

Immune-related adverse events during neoadjuvant and adjuvant therapy

graphic file with name 41586_2022_5368_Tab2_ESM.jpg